Cytek Biosciences Inc — Stato Patrimoniale (NASDAQ:CTKB) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Totale attivo 463.31 M519.48 M494.46 M499.5 M461.54 M Totale passività 57.92 M93.93 M101.39 M103.76 M119.8 M Patrimonio netto totale 405.38 M425.55 M393.06 M395.74 M341.74 M Totale passività e patrimonio netto 463.31 M519.48 M494.46 M499.5 M461.54 M Debito totale —17.51 M13.57 M12.36 M17.45 M Indebitamento netto —-279.09 M-153.73 M-86.36 M-73.41 M

Notizie

Cytek Biosciences alla TD Cowen Health Care: Approfondimenti sulla Crescita Strategica

Cytek Biosciences at TD Cowen Health Care: Strategic Growth Insights

Cytek Biosciences, Inc. (CTKB) Q4 2025 Earnings Call Transcript

Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates

Cytek Biosciences earnings missed by $0.32, revenue topped estimates

Cytek Biosciences, Inc. (CTKB) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:CTKB) 2026-01-15

Cytek Biosciences, Inc. (CTKB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Cytek Biosciences Is A Speculative Buy On Recurring Revenue Growth (CTKB)

Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday - Beyond Meat (NASDAQ:BYND), Avadel Pharmaceuticals (NASDAQ:AVDL)

Cytek Biosciences, Inc. (CTKB) Q3 2025 Earnings Call Transcript

Cytek Biosciences, Inc. (CTKB) Reports Q3 Loss, Tops Revenue Estimates

Alvotech (ALVO) Surges 8.6%: Is This an Indication of Further Gains?